Lymphangioleiomyomatosis
- PMID: 27514586
- DOI: 10.1016/j.ccm.2016.04.002
Lymphangioleiomyomatosis
Abstract
Lymphangioleiomyomatosis is a rare multisystem disease predominantly affecting women that can occur sporadically or in association with tuberous sclerosis. Lung cysts progressively replace the lung parenchyma, which leads to dyspnea, recurrent pneumothorax, and in some cases respiratory failure. Patients may also have lymphatic disease in the thorax, abdomen, and pelvis, and renal angiomyolipomas. Treatment includes supportive care, bronchodilators, and for those with progressive disease, mammalian target of rapamycin (mTOR) inhibitors.
Keywords: Angiomyolipoma; Cystic lung disease; Lymphatic disease; Pneumothorax; mTOR inhibitor.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Unusual presentation of tuberous sclerosis complex.Urology. 2012 Oct;80(4):e39-40. doi: 10.1016/j.urology.2012.06.016. Epub 2012 Aug 15. Urology. 2012. PMID: 22901821 No abstract available.
-
Lymphangioleiomyomatosis: pulmonary and abdominal findings with pathologic correlation.Radiographics. 2002 Oct;22 Spec No:S185-98. doi: 10.1148/radiographics.22.suppl_1.g02oc13s185. Radiographics. 2002. PMID: 12376610 Review.
-
Conservative management of pulmonary lymphangioleiomyomatosis and tuberous sclerosis complicated by renal angiomyolipomas in pregnancy.J Matern Fetal Neonatal Med. 2004 Feb;15(2):132-4. doi: 10.1080/14767050410001659879. J Matern Fetal Neonatal Med. 2004. PMID: 15209123
-
Coexisting lymphangioleiomyomatosis and bilateral angiomyolipomas in a patient with tuberous sclerosis.J Urol. 1994 Jun;151(6):1612-5. doi: 10.1016/s0022-5347(17)35317-x. J Urol. 1994. PMID: 8189576
-
Bilateral renal angiomyolipomatosis in tuberous sclerosis presenting with chronic renal failure: case report and review of the literature.Nephron. 1994;68(2):256-8. doi: 10.1159/000188267. Nephron. 1994. PMID: 7830866 Review.
Cited by
-
A Mixed Blood-Lymphatic Endothelial Cell Phenotype in Lymphangioleiomyomatosis and Idiopathic Pulmonary Fibrosis but Not in Kaposi's Sarcoma or Tuberous Sclerosis Complex.Am J Respir Cell Mol Biol. 2022 Mar;66(3):337-340. doi: 10.1165/rcmb.2021-0293LE. Am J Respir Cell Mol Biol. 2022. PMID: 35102814 Free PMC article. No abstract available.
-
ETV2 regulates PARP-1 binding protein to induce ER stress-mediated death in tuberin-deficient cells.Life Sci Alliance. 2022 Feb 18;5(5):e202201369. doi: 10.26508/lsa.202201369. Print 2022 May. Life Sci Alliance. 2022. PMID: 35181635 Free PMC article.
-
Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment.Nat Commun. 2022 Aug 26;13(1):5018. doi: 10.1038/s41467-022-32673-7. Nat Commun. 2022. PMID: 36028490 Free PMC article.
-
Rates of change in FEV1 and DLCO as potential indicators for mTOR inhibitor therapy in premenopausal lymphangioleiomyomatosis patients.Eur Respir J. 2018 Apr 19;51(4):1702258. doi: 10.1183/13993003.02258-2017. Print 2018 Apr. Eur Respir J. 2018. PMID: 29519926 Free PMC article.
-
Long-Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis.Chest. 2018 Jan;153(1):124-132. doi: 10.1016/j.chest.2017.05.012. Epub 2017 May 19. Chest. 2018. PMID: 28533049 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous